This protein engineering firm claims its therapies, modeled on the naturally secreted human serum protein tetranectin, could compete with antibodies. With the global economy still in the throes of the ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Anaphore today announced it has raised an additional $13 million in a second closing to its Series A Preferred Stock financing announced in January 2009, bringing ...
RuiYi was founded by Raymond Stevens, PhD., of The Scripps Research Institute (TSRI) and TSRI alumni Fei Xu, Ph.D. of Shanghai, China. “The acquisition of RuiYi in China allows Anaphore to access the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果